BEAT-SHOCK Registry
NCT07643610
Acute Decompensated Heart Failure, Cardiogenic Shock
Basel, Canton of Basel-City, Switzerland
View Trial DetailsNCT Number: NCT06697093
The registry objective is to get information on current epidemiology, diagnostics, treatment and outcome in patients with cardiogenic shock in Poland. Obtained information will help to plan the nationwide initiative for modern cardiogenic shock treatment with established place for mechanical circulatory support.
It is hypothesized that the treatment and outcome of cardiogenic shock, including mechanical circulatory support, are currently poor in Poland and should be improved. Unfortunately, without status quo data, efficient planning for its improvement cannot be conducted, hence the CaS-POL registry initiative.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland, Wroclaw, Lower Silesian Voivodeship, Poland
The prospective registry will be open in nature; any cardiology department in Poland with access to a 24-hour hemodynamic laboratory will be eligible to participate in the study. All participants will use an electronic CRF (Case Report Form) to anonymously collect data on the incidence, etiology, diagnosis, treatment approaches, and prognosis of patients with cardiogenic shock. Data will be collected by researchers from the medical documentation of participating centers. The data collection period will span six months, followed by a six-month prospective observation through visit in person, per telephone contact to the patient or his/her relatives or by retracting National Health Fund data in case the contact to the patient or his/her relatives is impossible.
To enable comparison with global data, collected information will include, among other aspects, the latest Society for Cardiovascular Angiography and Interventions (SCAI) classification for cardiogenic shock, the availability and application of modern short- and long-term mechanical circulatory support techniques, and the frequency of heart transplants.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From the date of cardiogenic shock diagnosis recognition until the date of death from any cause assessed up to 6 months
all-cause mortality
Time frame: From the date of cardiogenic shock diagnosis recognition until the date of first documented myocardial infarction assessed up to 6 months
Recurrent myocardial infarction following an initial event
Time frame: From the date of cardiogenic shock diagnosis recognition until the date of first documented stroke assessed up to 6 months
stroke following an initial event
Time frame: From the date of cardiogenic shock diagnosis recognition until the date of heart transplantation assessed up to 6 months
Heart transplantation in patients without myocardial recovery following cardiogenic shock.
Time frame: From the date of cardiogenic shock diagnosis recognition until the date of long-term LVAD assessed up to 6 months
Long-term LVAD implantation in patients without myocardial recovery following cardiogenic shock
Contact information is provided by the study sponsor or research team.
Mikołaj Błaziak, MD
CONTACT
Wiktor Kuliczkowski, MD,PhD
CONTACT
Wroclaw Medical University
Other
Polish Nationwide Registry of Diagnostics, Treatment and Outcome in Patients With Cardiogenic Shock CaS-POL
Acronym: CaS-POL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07643610
Acute Decompensated Heart Failure, Cardiogenic Shock
Basel, Canton of Basel-City, Switzerland
View Trial DetailsNCT07597291
Cardiogenic Shock, Cardiogenic Shock Acute
Carnaxide, Lisbon District, Portugal
View Trial DetailsNCT05168462
Cardiogenic Shock, Cardiovascular Diseases
Amsterdam, Netherlands
View Trial DetailsNCT06955936
Cardiogenic Shock, Cardiovascular Diseases
Tomsk, Russia
View Trial Details